Literature DB >> 20592726

Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

S-H Chen1, D Pei, W Yang, C Cheng, S Jeha, N J Cox, W E Evans, C-H Pui, M V Relling.   

Abstract

The genetic variations that result in allergy to asparaginase are as yet undetermined. We interrogated more than 500,000 single-nucleotide polymorphisms (SNPs) in 485 children with acute lymphoblastic leukemia (ALL), 322 in a discovery cohort, and 163 in a validation cohort. In the top 100 SNPs associated with allergy in the discovery cohort, chromosome 5 was overrepresented as compared with other chromosomes (P = 0.00032), hosting 10 SNPs annotated to genes. Among these 10 SNPs, one SNP (rs4958351) [corrected], in GRIA1 on chromosome 5q33, was replicated in the validation cohort (P = 1.8 x 10(-5), 2.9 x 10(-3), and 3.5 x 10(-7) in the discovery, validation, and combined cohorts, respectively). Four additional SNPs annotated to GRIA1 were also significantly associated with allergy (P < 0.05) in both cohorts. Chromosome 5q33 has previously been associated with asthma and atopy. These data contribute to the growing body of evidence that there is an inherited component to predisposition to drug allergy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592726      PMCID: PMC3000799          DOI: 10.1038/clpt.2010.94

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  51 in total

1.  Genome-wide search for atopy susceptibility genes in Dutch families with asthma.

Authors:  Gerard H Koppelman; O Colin Stine; Jianfeng Xu; Timothy D Howard; Siqun L Zheng; Henk F Kauffman; Eugene R Bleecker; Deborah A Meyers; Dirkje S Postma
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

2.  A genome-wide search for allergic response (atopy) genes in three ethnic groups: Collaborative Study on the Genetics of Asthma.

Authors:  Malcolm N Blumenthal; Carl D Langefeld; Terri H Beaty; Eugene R Bleecker; Carole Ober; Lucille Lester; Ethan Lange; Kathleen C Barnes; Raoul Wolf; Richard A King; Julian Solway; William Oetting; Deborah A Meyers; Stephen S Rich
Journal:  Hum Genet       Date:  2003-10-25       Impact factor: 4.132

3.  Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Authors:  S Mallal; D Nolan; C Witt; G Masel; A M Martin; C Moore; D Sayer; A Castley; C Mamotte; D Maxwell; I James; F T Christiansen
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

4.  Toxicity of E. coli L-asparaginase in man.

Authors:  H F Oettgen; P A Stephenson; M K Schwartz; R D Leeper; L Tallai; C C Tan; B D Clarkson; R B Golbey; I H Krakoff; D A Karnofsky; M L Murphy; J H Burchenal
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

5.  Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia.

Authors:  C B Pratt; S I Choi; C P Holton
Journal:  Am J Dis Child       Date:  1971-05

6.  Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.

Authors:  C B Pratt; J V Simone; P Zee; R J Aur; W W Johnson
Journal:  J Pediatr       Date:  1970-09       Impact factor: 4.406

7.  Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations.

Authors:  Arlene R Hughes; Michael Mosteller; Aruna T Bansal; Kirstie Davies; Stephen A Haneline; Eric H Lai; Keith Nangle; Trevor Scott; William R Spreen; Liling L Warren; Allen D Roses
Journal:  Pharmacogenomics       Date:  2004-03       Impact factor: 2.533

8.  Immunological responses to L-asparaginase.

Authors:  R G Peterson; R E Handschumacher; M S Mitchell
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

Review 9.  Gene polymorphisms within the immune system that may underlie drug allergy.

Authors:  Rob J Vandebriel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-03       Impact factor: 3.000

10.  Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.

Authors:  Annalise M Martin; David Nolan; Silvana Gaudieri; Coral Ann Almeida; Richard Nolan; Ian James; Filipa Carvalho; Elizabeth Phillips; Frank T Christiansen; Anthony W Purcell; James McCluskey; Simon Mallal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

View more
  32 in total

1.  Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia.

Authors:  C Liu; J D Kawedia; C Cheng; D Pei; C A Fernandez; X Cai; K R Crews; S C Kaste; J C Panetta; W P Bowman; S Jeha; J T Sandlund; W E Evans; C-H Pui; M V Relling
Journal:  Leukemia       Date:  2012-04-09       Impact factor: 11.528

Review 2.  Inherited genetic variation in childhood acute lymphoblastic leukemia.

Authors:  Takaya Moriyama; Mary V Relling; Jun J Yang
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

Review 3.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 4.  Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.

Authors:  Rochelle R Maxwell; Peter D Cole
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

5.  Asparaginase allergies: it's all in the genes.

Authors:  Meir Wetzler
Journal:  Blood       Date:  2014-08-21       Impact factor: 22.113

6.  Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge.

Authors:  Yiwei Liu; Colton A Smith; John C Panetta; Wenjian Yang; Lauren E Thompson; Jacob P Counts; Alejandro R Molinelli; Deqing Pei; Nancy M Kornegay; Kristine R Crews; Hope Swanson; Cheng Cheng; Seth E Karol; William E Evans; Hiroto Inaba; Ching-Hon Pui; Sima Jeha; Mary V Relling
Journal:  J Clin Oncol       Date:  2019-06-12       Impact factor: 44.544

7.  Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Chengcheng Liu; Deqing Pei; Cheng Cheng; Christian A Fernandez; Scott C Howard; Dario Campana; John C Panetta; W Paul Bowman; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

8.  Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.

Authors:  Mohsen Ben Tanfous; Bahram Sharif-Askari; Francesco Ceppi; Haithem Laaribi; Vincent Gagné; Julie Rousseau; Malgorzata Labuda; Lewis B Silverman; Stephen E Sallan; Donna Neuberg; Jeffery L Kutok; Daniel Sinnett; Caroline Laverdière; Maja Krajinovic
Journal:  Clin Cancer Res       Date:  2014-06-06       Impact factor: 12.531

Review 9.  Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.

Authors:  Emmanuel Peprah; Huichun Xu; Fasil Tekola-Ayele; Charmaine D Royal
Journal:  Public Health Genomics       Date:  2014-11-26       Impact factor: 2.000

10.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.